Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
ConditionOnychomycosis
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-60
SponsorZagazig University
About this trial
3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.
Eligibility criteria
Qualifiers
patients with onychomycosis
Disqualifiers
pregnant and lactating females patients on statin therapy or photosensitizing drugs patients with liver disease, heart disease and diabetes milletus.
Trial design
Treatments tested in this trial
- ISOtretinoin 10 MG
- excimer light
- Itraconazole 200 mg
Treatment groups
36 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov